Kitsap Provider Resources

Health Advisory: COVID-19 and Childhood Immunization Provider Updates and Reminder to Participate in KPHD COVID Response After Action Survey

Requested Actions COVID-19 VACCINE Be aware, on May 5, 2022, the Food and Drug Administration (FDA) limited the authorized use of the Johnson & Johnson (Janssen) COVID-19 Vaccine following an analysis of the risk of thrombosis with thrombocytopenia syndrome (TTS) after administration of the Janssen COVID-19 Vaccine to: People age 18 years and older for Health Advisory: COVID-19 and Childhood Immunization Provider Updates and Reminder to Participate in KPHD COVID Response After Action Survey

Health Advisory: Updated J&J Vaccine Recommendations

Requested actions Be aware, on December 16, Centers for Disease Control and Prevention (CDC) recommended mRNA COVID-19 vaccines (Pfizer or Moderna) over Johnson & Johnson (J&J) COVID-19 vaccine for all people 18 years or older. The recommendation is based on the increased risk of thrombosis with thrombocytopenia syndrome (TTS) after getting J&J COVID-19 vaccine. Be Health Advisory: Updated J&J Vaccine Recommendations

Health Advisory: COVID-19 UPDATES – BOOSTERS, EVUSHELD, and OMICRON VARIANT

Actions Requested Be aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup recommend everyone 16 years or older get a COVID-19 vaccine booster dose at the recommended interval. This recommendation comes after Food and Drug Administration (FDA) expanded its emergency use authorization (EUA) for Pfizer-BioNTech COVID-19 vaccine booster doses Health Advisory: COVID-19 UPDATES – BOOSTERS, EVUSHELD, and OMICRON VARIANT